Related Experiment Video
Updated: Aug 8, 2026

Use of In vivo Imaging to Monitor the Progression of Experimental Mouse Cytomegalovirus Infection in Neonates
Published on: July 6, 2013
A mouse cytomegalovirus glycoprotein retains MHC class I complexes in the ERGIC/cis-Golgi compartments
1Max von Pettenkofer Institut, Ludwig-Maximilians-Universitat, Munchen, Federal Republic of Germany.
Insights
Mouse cytomegalovirus uses the m152 gene to block antigen presentation. This novel mechanism arrests the export of mouse MHC class I complexes, evading cytotoxic T cell detection.
Area of Science:
- Virology
- Immunology
- Molecular Biology
Background:
- Mouse cytomegalovirus (MCMV) employs immune evasion strategies to ensure viral replication.
- MHC class I pathway presentation is crucial for adaptive immune responses, involving antigen processing and cell surface expression.
- Understanding viral interference with antigen presentation is key to developing antiviral therapies.
Purpose of the Study:
- To investigate the mechanism by which MCMV inhibits antigen presentation via the MHC class I pathway.
- To identify the specific viral gene responsible for this immune evasion.
- To characterize the function of the identified viral protein and its impact on host cell processes.
Main Methods:
- Gene expression analysis of MCMV genes in infected murine and human cells.
- Protein characterization of the identified viral glycoprotein (gp40).
- Cellular localization studies and analysis of MHC class I complex transport using immunofluorescence and biochemical assays.
- Cytotoxic T cell lysis assays to assess immune recognition.
Main Results:
- The MCMV gene m152 was identified as responsible for blocking antigen presentation.
- Expression of m152, encoding a 40 kDa glycoprotein (gp40), arrested the export of mouse MHC class I complexes from the ER-Golgi intermediate compartment.
- This arrest inhibited lysis by cytotoxic T cells, while human MHC class I transport remained unaffected.
- Deletion of the cytoplasmic tail of gp40 did not alter its effect on MHC class I export.
Conclusions:
- MCMV utilizes the m152 gene product, gp40, to block antigen presentation through a novel mechanism.
- This mechanism involves arresting MHC class I complex export from the ER-Golgi intermediate compartment, distinct from known viral immune evasion strategies.
- The findings reveal a new herpesvirus strategy for shutting off MHC class I function, offering insights into viral pathogenesis and immune evasion.
Abstract:
The principle by which mouse cytomegalovirus blocks antigen presentation in the MHC class I pathway was investigated. The responsible gene m152, encoding a type I transmembrane glycoprotein of 40 kDa, is a member of a gene family located in the right-hand terminal region of the 230 kb virus genome. Expression of m152 in murine and human cells arrested the export of mouse class I complexes from the ER-Golgi intermediate compartment/cis-Golgi compartment and inhibited lysis by cytotoxic T cells. The plasma membrane transport of human MHC class I molecules was not affected. The deletion of the cytoplasmic tail of gp40 did not lift its effect on class I molecule export, indicating that this protein differs in its functions from known immunosubversive viral gene products and represents a novel principle by which a herpesvirus shuts off MHC class I function.
Related Concept Videos
Intralumenal Vesicles and Multivesicular Bodies
Export of Misfolded Proteins out of the ER
Cytomegalovirus Disease

